These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7947873)

  • 1. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
    Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
    J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil (MMF) in heart transplantation: rejection prevention and treatment.
    Renlund DG; Gopinathan SK; Kfoury AG; Taylor DO
    Clin Transplant; 1996 Feb; 10(1 Pt 2):136-9. PubMed ID: 8680051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
    J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
    Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil: a unique immunosuppressive agent.
    Hood KA; Zarembski DG
    Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.
    Simmons WD; Rayhill SC; Sollinger HW
    Drug Saf; 1997 Aug; 17(2):75-92. PubMed ID: 9285199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA
    Curr Opin Cardiol; 1998 Mar; 13(2):117-21. PubMed ID: 9593551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas' heart transplant recipients.
    Bestetti RB; Souza TR; Lima MF; Theodoropoulos TA; Cordeiro JA; Burdmann EA
    Transplantation; 2007 Aug; 84(3):441-2. PubMed ID: 17700175
    [No Abstract]   [Full Text] [Related]  

  • 9. [Initial experience with mycophenolate mofetil (RS 61443) after kidney transplantation].
    Friedrich J; Erhard J
    Zentralbl Chir; 1994; 119(1):48-9. PubMed ID: 8147160
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of mycophenolate mofetil in liver transplant recipients.
    Detry O; de Roover A; Delwaide J; Meurisse M; Honoré P
    Expert Opin Pharmacother; 2003 Nov; 4(11):1949-57. PubMed ID: 14596648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualization of mycophenolate mofetil dose in renal transplant recipients.
    van Hest RM; Hesselink DA; Vulto AG; Mathot RA; van Gelder T
    Expert Opin Pharmacother; 2006 Mar; 7(4):361-76. PubMed ID: 16503809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil in kidney transplantation.
    Lui SL; Halloran PF
    Curr Opin Nephrol Hypertens; 1996 Nov; 5(6):508-13. PubMed ID: 8978998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients.
    Lietz K; John R; Schuster M; Ankersmit J; Burke E; Suciu-Foca N; Edwards N; Mancini D; Itescu S
    Transplant Proc; 2002 Aug; 34(5):1828-9. PubMed ID: 12176593
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of mycophenolate mofetil on hematocrit after renal transplantation.
    Chenhsu RY; Wu YM; Min DI; Zimmerman MB
    Ann Pharmacother; 2002 Sep; 36(9):1479-80. PubMed ID: 12196073
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of Mycophenolate Mofetil (Cellcept) in renal transplantation.
    Vanrenterghem Y
    Nephron; 1997; 76(4):392-9. PubMed ID: 9274835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
    Sánchez V; Delgado JF; Blasco T; Dalmau R; Morales JM; Escribano P; Tello R; Hernández J; Velázquez T; Sotelo T; Gómez-Sánchez MA; Sáenz de la Calzada C
    Transplant Proc; 1999 Sep; 31(6):2515-6. PubMed ID: 10500695
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil for the transplanted kidney?
    Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving role of mycophenolate mofetil in renal transplantation.
    Warrens AN
    QJM; 2000 Jan; 93(1):15-20. PubMed ID: 10623777
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee--Japan.
    Takahashi K; Ochiai T; Uchida K; Yasumura T; Ishibashi M; Suzuki S; Otsubo O; Isono K; Takagi H; Oka T
    Transplant Proc; 1995 Feb; 27(1):1421-4. PubMed ID: 7878933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.